Edition:
India

MDxHealth SA (MDXH.BR)

MDXH.BR on Brussels Stock Exchange

3.76EUR
18 May 2018
Change (% chg)

€0.06 (+1.62%)
Prev Close
€3.69
Open
€3.72
Day's High
€3.76
Day's Low
€3.68
Volume
232,405
Avg. Vol
225,045
52-wk High
€5.20
52-wk Low
€2.89

Select another date:

Thu, Apr 26 2018

BRIEF-MDxHealth Announces Positive Clinical Updates For ConfirmMDx

* REG-MDXHEALTH ANNOUNCES POSITIVE CLINICAL UPDATES FOR CONFIRMMDX

BRIEF-Mdxhealth Q1 Operating Loss widens to 6.7 Million Dollars

* Q1 TOTAL REVENUE OF $9.7 MILLION, UP 50% FROM $6.5 MILLION IN Q1 2017

BRIEF-Mdxhealth: Inclusion Of Selectmdx In Dutch Diagnosis Related Groups Reimbursement System

* INCLUSION OF SELECTMDX FOR PROSTATE CANCER IN DUTCH DIAGNOSIS RELATED GROUPS (DRG) REIMBURSEMENT SYSTEM Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-3D Signatures Signed Collaboration Agreement With Mdxhealth SA To Evaluate Co's Prognostic Test Candidate For Prostate Cancer

* 3D SIGNATURES - SIGNED COLLABORATION AGREEMENT WITH MDXHEALTH SA TO EVALUATE CO'S PROGNOSTIC TEST CANDIDATE FOR PROSTATE CANCER

BRIEF-Bookrunner On MDxHealth Books Says Accelerated Bookbuilding Of Offering Of Up To 9.9 Million

* BLOCK TRADE : MDXHEALTH SA - BOOKRUNNER SAYS ACCELERATED BOOKBUILDING OF OFFERING OF UP TO 9.9 MILLION NEW SHARES OR UP TO ABOUT 20 PERCENT OF CURRENT SHARE CAPITAL

BRIEF-MDxHealth Says SelectMDx Liquid Biopsy Test In 2018 European Association Urology Guidelines

* REG-MDXHEALTH (R): SELECTMDX LIQUID BIOPSY TEST FOR PROSTATE CANCER INCLUDED IN THE 2018 EUROPEAN ASSOCIATION UROLOGY GUIDELINES

BRIEF-Mdx Pcl Posts Fy Net Profit Of 221 Mln Baht

* FY TOTAL REVENUES 267.1 MILLION BAHT VERSUS 241.2 MILLION BAHT

BRIEF-Mdxhealth Contract Selectmdx With Roman Hospital

* ‍MDXHEALTH ENTERS INTO COMMERCIAL AGREEMENT FOR SELECTMDX WITH FONDAZIONE LUIGI MARIA MONTI - ISTITUTO DERMOPATICO DELL' IMMACOLATA HOSPITAL IN ROME​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Mdxhealth FY Total Revenue Up 35 pct at 40 Million Dollars

* FY TOTAL REVENUE OF $40 MILLION UP 35% WITH CONTINUED STRONG VOLUME GROWTH

BRIEF-MDxHealth ‍Develops Blood Test For Prostate Cancer Patients​

* ‍DEVELOPS BLOOD TEST TO GUIDE PRECISION-TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS​

Select another date: